Related Experiment Video
Updated: Jul 4, 2025

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance
Min Ma1, Yazhi Zhu1, Changkai Xiao2
1Institute of Translational Medicine, School of Basic Medical, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Abstract:
Prostate cancer is the second most common malignancy among men in the world, posing a serious threat to men's health and lives. RB1 is the first human tumor suppressor gene to be described, and it is closely associated with the development, progression, and suppression of a variety of tumors. It was found that the loss of RB1 is an early event in prostate cancer development and is closely related to prostate cancer development, progression and treatment resistance. This paper reviews the current status of research on the relationship between RB1 and prostate cancer from three aspects: RB1 and prostate cell lineage plasticity; biological behavior; and therapeutic resistance. Providing a novel perspective for developing new therapeutic strategies for RB1-loss prostate cancer.
Insights
Loss of the RB1 tumor suppressor gene is an early event in prostate cancer, linked to disease progression and treatment resistance. Understanding RB1
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer is a leading global malignancy affecting men's health.
- The RB1 gene is a critical human tumor suppressor involved in various cancers.
- RB1 loss is an early event in prostate cancer, impacting progression and treatment resistance.
Purpose of the Study:
- To review the current research on the relationship between RB1 and prostate cancer.
- To explore RB1's role in prostate cancer cell lineage plasticity, biological behavior, and therapeutic resistance.
- To offer a new perspective for developing therapeutic strategies for RB1-loss prostate cancer.
Main Methods:
- Literature review of studies on RB1 and prostate cancer.
- Analysis of RB1's involvement in prostate cancer development and progression.
- Examination of RB1's role in treatment resistance.
Main Results:
- RB1 loss is an early event in prostate cancer.
- RB1 is associated with prostate cancer development, progression, and treatment resistance.
- RB1 influences prostate cancer cell lineage plasticity and biological behavior.
Conclusions:
- RB1 plays a significant role in prostate cancer.
- Targeting RB1 may offer new therapeutic strategies for prostate cancer patients.
- Further research into RB1's functions can advance prostate cancer treatment.
More Related Videos
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Treatment Resistant Cancers
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Negative Regulator Molecules
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...